124 research outputs found

    Broilers perform better on short or step-up photoperiods

    Get PDF
    Rearing broilers on 6-h photoperiods and transferring them to 23 h at 21 d has been shown to reduce mortality and the incidence of leg disorders without adversely affecting final body weight or feed conversion efficiency. However, in many countries, welfare codes for meat chickens currently stipulate a minimum photoperiod of 8 h, and are likely to specify a minimum uninterrupted dark period of 8 h in the future. This paper reports a study of the response of two genotypes of broiler females to a lighting regimen that complies with these requirements: an initial 8-h photoperiod followed by a 16-h photoperiod from 21 to 42 d. Constant 8- and 16-h photoperiods were provided as controls. The two breeds responded similarly to all lighting treatments. Constant 8-h and photostimulated birds had significantly heavier body weights, and strong tendencies towards larger feed intakes and superior feed conversion, than the 16-h controls. Lighting treatment had no significant effect on mortality or the incidence of leg problems. Ross birds had a significantly slower growth to 21 d, higher feed intake after 21 d, and inferior feed conversion efficiency throughout than Cobb birds. Ross birds had significantly lower mortality and fewer leg disorders than Cobb, due possibly to their slower initial growth. South African Journal of Animal Science Vol. 37 (2) 2007: pp. 90-9

    An exploration of the accentuation effect: errors in memory for voice fundamental frequency (F0) and speech rate

    Get PDF
    The accentuation effect demonstrates how memory often reflects category typical representations rather than the specific features of learned items. The present study investigated the impact of manipulating fundamental frequency (F0) and speech rate (syllables per second) on immediate target matching performance (selecting a voice from a pair to match a previously heard target voice) for a range of synthesised voices. It was predicted that when participants were presented with high or low frequency target voices, voices even higher or lower in frequency would be selected. The same pattern was also predicted for speech rate. Inconsistent with the accentuation account, the results showed a general bias to select voices higher in frequency for high, moderate, and low frequency target voices. For speech rate, listeners selected voices faster in rate for slow rate target voices. Overall it seems doubtful that listeners rely solely on categorical information about voices during recognition

    Review: Amylopectin synthesis and hydrolysis – understanding isoamylase and limit dextrinase and their impact on starch structure on barley (Hordeum vulgare) quality

    Get PDF
    Background Starch contributes to barley grain and malt quality which in turn contributes to beer quality and flavour; through fermentable sugar profiles, rates of fermentation and Mallard reactions. Both amylopectin and amylose are enzymatically degraded to release maltose, maltotriose and higher order sugars. Scope and approach Amylopectin is highly branched [α-(1\ua0→\ua06) glycoside bond branch points] with numerous short branches while amylose is a long chained polymer with a few side branches. During grain development, the final level of branching is controlled by two enzymes namely; isoamylase and limit dextrinase (LD). Mutations in either of these genes can also result in changes to structure, content, and granule formation and size. During the malting free LD will to cleave the α-(1\ua0→\ua06) bonds but during mashing processes, bound LD is release, resulting in chains of various length available for other starch degrading enzymes to hydrolyse. Findings and conclusions While there is a good understanding of most of the individual aspects in amylopectin formation, structure and degradation; the story remains incomplete, as most of this understanding has been gained from experiments with only a limited number of barley varieties, limitations in the technology for structural measurement, and since no data is available to link structure to fermentable sugar profiles

    Investigating the need for therapeutic drug monitoring of imipenem in critically ill patients: Are we getting it right?

    Get PDF
    Background. The drug levels and clearances of imipenem in critically ill patients are not comprehensively described in current literature, yet it is vital that adequate levels be achieved for therapeutic success.Objectives. To determine the proportion of critically ill patients treated with imipenem/cilastatin with sub-therapeutic imipenem plasma levels, and to compare the clinical outcomes of those patients with therapeutic levels with those who had sub-therapeutic levels.Methods. Trough imipenem plasma levels of 68 critically ill patients from a surgical intensive care unit were measured using a validated high-performance liquid chromatography method. Imipenem trough levels were compared with the minimum inhibitory concentration (MIC) of the causative bacterial agents, based on a target value of 100% time above MIC (¦T >MIC).Results. The proportion of participants with sub-therapeutic imipenem levels was 22% (95% confidence interval (CI) 13% - 34%). The 14- and 28-day mortality rates in the sub-therapeutic group were 33% and 40%, respectively, compared with 19% (p=0.293) and 26% (p=0.346), respectively, in the therapeutic group. Sub-therapeutic imipenem plasma levels are associated with adjusted hazard ratio of 1.47 (95% CI 0.55 - 3.91).Conclusions. The lower proportion of critically ill patients with sub-therapeutic imipenem plasma levels in this study compared with previous studies may be attributed to the practice of higher dosages and the administration method of extended infusions of imipenem/cilastatin in our setting. The results demonstrate a trend of higher mortality in patients with sub-therapeutic imipenem levels, although the results were not statistically significant at this sample size.

    Investigating the need for therapeutic drug monitoring of imipenem in critically ill patients: Are we getting it right?

    Get PDF
    Background. The drug levels and clearances of imipenem in critically ill patients are not comprehensively described in current literature, yet it is vital that adequate levels be achieved for therapeutic success. Objectives. To determine the proportion of critically ill patients treated with imipenem/cilastatin with sub-therapeutic imipenem plasma levels, and to compare the clinical outcomes of those patients with therapeutic levels with those who had sub-therapeutic levels. Methods. Trough imipenem plasma levels of 68 critically ill patients from a surgical intensive care unit were measured using a validated high-performance liquid chromatography method. Imipenem trough levels were compared with the minimum inhibitory concentration (MIC) of the causative bacterial agents, based on a target value of 100% time above MIC (ƒT >MIC). Results. The proportion of participants with sub-therapeutic imipenem levels was 22% (95% confidence interval (CI) 13% - 34%). The 14- and 28-day mortality rates in the sub-therapeutic group were 33% and 40%, respectively, compared with 19% (p=0.293) and 26% (p=0.346), respectively, in the therapeutic group. Sub-therapeutic imipenem plasma levels are associated with adjusted hazard ratio of 1.47 (95% CI 0.55 - 3.91). Conclusions. The lower proportion of critically ill patients with sub-therapeutic imipenem plasma levels in this study compared with previous studies may be attributed to the practice of higher dosages and the administration method of extended infusions of imipenem/ cilastatin in our setting. The results demonstrate a trend of higher mortality in patients with sub-therapeutic imipenem levels, although the results were not statistically significant at this sample size

    Predicted optimum ambient temperatures for broiler chickens to dissipate metabolic heat do not affect performance or improve breast muscle quality

    Get PDF
    <p></p><p>An experiment was conducted to test the hypothesis that muscle damage in fast-growing broiler chickens is associated with an ambient temperature that does not permit the birds to lose metabolic heat resulting in physiological heat stress and a reduction in meat quality.</p><p>The experiment was performed in 4 climate chambers and was repeated in 2 trials using a total of 200 male broiler chickens. Two treatments compared the recommended temperature profile and a cool regimen. The cool regimen was defined by a theoretical model that determined the environmental temperature that would enable heat generated by the bird to be lost to the environment.</p><p>There were no differences in growth rate or feed intake between the two treatments. Breast muscles from birds on the recommended temperature regimen were lighter, less red and more yellow than those from the cool temperature regimen. There were no differences in moisture loss or shear strength but stiffness was greater in breast muscle from birds housed in the cool compared to the recommended regimen.</p><p>Histopathological changes in the breast muscle were similar in both treatments and were characterised by mild to severe myofibre degeneration and necrosis with regeneration, fibrosis and adipocyte infiltration. There was no difference in plasma creatine kinase activity, a measure of muscle cell damage, between the two treatments consistent with the absence of differences in muscle pathology.</p><p>It was concluded that breast muscle damage in fast-growing broiler chickens was not the result of an inability to lose metabolic heat at recommended ambient temperatures. The results suggest that muscle cell damage and breast meat quality concerns in modern broiler chickens are related to genetic selection for muscle yields and that genetic selection to address breast muscle integrity in a balanced breeding programme is imperative.</p><p></p> <p>An experiment was conducted to test the hypothesis that muscle damage in fast-growing broiler chickens is associated with an ambient temperature that does not permit the birds to lose metabolic heat resulting in physiological heat stress and a reduction in meat quality.</p> <p>The experiment was performed in 4 climate chambers and was repeated in 2 trials using a total of 200 male broiler chickens. Two treatments compared the recommended temperature profile and a cool regimen. The cool regimen was defined by a theoretical model that determined the environmental temperature that would enable heat generated by the bird to be lost to the environment.</p> <p>There were no differences in growth rate or feed intake between the two treatments. Breast muscles from birds on the recommended temperature regimen were lighter, less red and more yellow than those from the cool temperature regimen. There were no differences in moisture loss or shear strength but stiffness was greater in breast muscle from birds housed in the cool compared to the recommended regimen.</p> <p>Histopathological changes in the breast muscle were similar in both treatments and were characterised by mild to severe myofibre degeneration and necrosis with regeneration, fibrosis and adipocyte infiltration. There was no difference in plasma creatine kinase activity, a measure of muscle cell damage, between the two treatments consistent with the absence of differences in muscle pathology.</p> <p>It was concluded that breast muscle damage in fast-growing broiler chickens was not the result of an inability to lose metabolic heat at recommended ambient temperatures. The results suggest that muscle cell damage and breast meat quality concerns in modern broiler chickens are related to genetic selection for muscle yields and that genetic selection to address breast muscle integrity in a balanced breeding programme is imperative.</p
    corecore